Sign In
Buy ARTL
$0.770
+0.0148 (+1.96%)
At Close: Jul 31, 2026
Southern California Bancorp Announces Results for the Second Quarter 2020
12:00am, Monday, 27'th Jul 2020
Southern California Bancorp (the “Company”) (OTC Pink: BCAL), the holding company for Bank of Southern California, N.A. (the “Bank”) today reported re
Artelo Biosciences Reports Q3 Results, Talks Patent For Cocrystal CBD
12:00am, Wednesday, 15'th Jul 2020
Artelo Biosciences (NASDAQ: ARTL) announced its third-quarter results as of May 31.
The La Jolla, California-based company reported a net loss of $951,191,...
Artelo Biosciences Reports Third Quarter Fiscal Year 2020 Financial Results and Provides Business Update
01:25pm, Tuesday, 14'th Jul 2020
LA JOLLA, Calif., July 14, 2020 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate the end
The Endocannabinoid System: How Cannabis Interacts With The Body
12:00am, Tuesday, 07'th Jul 2020
This article was originally published on The Cannigma, and appears here with permission.
Discovered by scientists in the early 1990s, the endocannabinoid system is responsible...
Artelo Biosciences, Inc. (ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate the endocannabinoid system, today announced that it has expanded it
Clouds the Likely Cause of Increased Global Warming in Latest Generation of Climate Models
10:08pm, Saturday, 27'th Jun 2020
New representations of clouds are making models more sensitive to carbon dioxide. As scientists work to determine why some of the latest climate models suggest the future could be warmer than previous
CBD Brand ECS Buys R&D Facility, Equipment From Dean Foods
12:00am, Wednesday, 24'th Jun 2020
ECS Brands recently announced an acquisition of a 10,000 square foot research and development facility formerly occupied by Dean Foods in Broomfield, Colorado.
This deal...
Phytocannabinoids & the ECS: Your Top Qs, Answered! | WholeFoods Magazine
04:00pm, Thursday, 18'th Jun 2020
Last year, in our 5th annual deep-dive into the phytocannabinoid market, we explored the research, regulatory issues, legal concerns, and more. It was only 12 months ago, but to say a lot has changed
Nurturing the ECS: Experts’ Top Tips | WholeFoods Magazine
03:54pm, Thursday, 18'th Jun 2020
There are many ways to support the endocannabinoid system (ECS) beyond supplementation with hemp and CBD. Michael D. Lewis, M.D., of CV Sciences, gives a rundown: “Exercise boosts your endocannabino
CJEU Says Copyright Protection May Apply to Product Designs if Technical Result Doesn’t Prevent Creative Choice
11:15am, Thursday, 18'th Jun 2020
On June 11, the Fifth Chamber of the Court of Justice of the European Union issued a decision holding that European copyright law extends protection to product shapes producing a technical result when
Unlock the Potential of Unstructured Data with DataIQ | Direct2DellEMC
12:00pm, Tuesday, 16'th Jun 2020
Data determines the winners and losers in the digital age If we examine the top trends many organizations are focused on today—harnessing big data and
Dell updates Isilon with PowerScale label, fresh hardware and other tweaks – Blocks and Files
11:13am, Tuesday, 16'th Jun 2020
Dell has updated its Isilon scale-out filers with new PowerScale branding and products as well as S3 object access and a DataIQ data analytics feature. PowerScale is the brand that Dell deputy chairma
Solutions Architect vs. Developer: An AWS Certification Breakdown
02:36am, Tuesday, 09'th Jun 2020
Which is right for you?
American Superconductor Corp. (AMSC) CEO Daniel McGahn on Q4 2020 Results - Earnings Call Transcript
06:18pm, Wednesday, 03'rd Jun 2020
American Superconductor Corp. (NASDAQ:AMSC) Q4 2020 Results Conference Call June 03, 2020 10:00 AM ET Company Participants John Heilshorn - LHA, IR Daniel McGah
Artelo Biosciences to Participate in BIO Digital and The Investor Summit Conferences
01:30pm, Wednesday, 03'rd Jun 2020
LA JOLLA, Calif., June 03, 2020 -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate the endocannabinoid.
